The effect of nanostructures of Latanoprost on male pattern hair loss

Evaluation of the effect of nanostructured lipid carriers containing latanoprost to control androgenic alopecia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211209053339N1

Enrollment

Registered

2022-01-15

Start date

2022-01-30

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia. Androgenic alopecia

Interventions

Intervention 1: Intervention group: Evaluation of the effect of lipid nanostructures containing latanoprost in the form of lotion on androgenic hair loss in male volunteers who will take the drug ever

Eligibility

Sex/Gender

Male

Age

23 Years to 50 Years

Inclusion criteria

Inclusion criteria: Male gender Age between 23 to 50 years manifestations of androgenic hair loss

Exclusion criteria

Exclusion criteria: History of skin cancer History of physical therapy on the scalp during the last 6 months Manifestations of skin disease in the desired area History of hair transplantation

Design outcomes

Primary

Measure	Time frame
Hair diameter. Timepoint: Before starting treatment and also at weeks 4, 8, 12, 16, 20 and 24. Method of measurement: Trichoscope.;Hair color. Timepoint: Before starting treatment and also at weeks 4, 8, 12, 16, 20 and 24. Method of measurement: Trichoscope.;Hair density. Timepoint: Before starting treatment and also at weeks 4, 8, 12, 16, 20 and 24. Method of measurement: Trichoscope.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShadi Mahramfar

Tabriz University of Medical Sciences

Shadi1995mahramfar@yahoo.com+98 41 3335 5389

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026